307 related articles for article (PubMed ID: 6967875)
1. Vitamin D metabolism in hypoparathyroidism.
Lund B; Sørensen OH; Lund B; Bishop JE; Norman AW
J Clin Endocrinol Metab; 1980 Sep; 51(3):606-10. PubMed ID: 6967875
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D metabolites in serum from hypoparathyroid patients treated with vitamin D2 and 1 alpha-hydroxyvitamin D3.
Aksnes L; Aarskog D
J Clin Endocrinol Metab; 1980 Oct; 51(4):823-9. PubMed ID: 6968318
[TBL] [Abstract][Full Text] [Related]
3. Demonstration of a lack of change in serum 1 alpha,25-dihydroxyvitamin D in response to parathyroid extract in pseudohypoparathyroidism.
Lambert PW; Hollis BW; Bell NH; Epstein S
J Clin Invest; 1980 Oct; 66(4):782-91. PubMed ID: 7419719
[TBL] [Abstract][Full Text] [Related]
4. [Plasma vitamin D metabolites in parathyroid diseases (author's transl)].
Unakami H
Nihon Naibunpi Gakkai Zasshi; 1982 Mar; 58(3):234-47. PubMed ID: 6980145
[TBL] [Abstract][Full Text] [Related]
5. Hypoparathyroidism during pregnancy: treatment with calcitriol.
Salle BL; Berthezene F; Glorieux FH; Delvin EE; Berland M; David L; Varenne JP; Putet G
J Clin Endocrinol Metab; 1981 Apr; 52(4):810-3. PubMed ID: 6894151
[TBL] [Abstract][Full Text] [Related]
6. Radioligand receptor assay for 25-hydroxyvitamin D2/D3 and 1 alpha, 25-dihydroxyvitamin D2/D3.
Hughes MR; Baylink DJ; Jones PG; Haussler MR
J Clin Invest; 1976 Jul; 58(1):61-70. PubMed ID: 1084355
[TBL] [Abstract][Full Text] [Related]
7. Normal intrauterine development of the fetus of a woman receiving extraordinarily high doses of 1,25-dihydroxyvitamin D3.
Marx SJ; Swart EG; Hamstra AJ; DeLuca HF
J Clin Endocrinol Metab; 1980 Nov; 51(5):1138-42. PubMed ID: 6893458
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and metabolic clearance of 1,25-dihydroxyvitamin D as determinants of serum concentrations: a comparison of two methods.
Maierhofer WJ; Gray RW; Adams ND; Smith GA; Lemann J
J Clin Endocrinol Metab; 1981 Sep; 53(3):472-5. PubMed ID: 6897931
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D-deficiency in the elderly: treatment with ergocalciferol and hydroxylated analogues of vitamin D3.
Shany S; Chaimovitz C; Yagev R; Bercovich M; Lowenthal MN
Isr J Med Sci; 1988 Mar; 24(3):160-3. PubMed ID: 3259568
[TBL] [Abstract][Full Text] [Related]
10. Serum concentrations of 25-hydroxyvitamin D and 24,25-dihydroxyvitamin D in patients with various types of renal disease.
Kano K; Nonoda A; Yoneshima H; Suda T
Clin Nephrol; 1980 Dec; 14(6):274-9. PubMed ID: 6970645
[TBL] [Abstract][Full Text] [Related]
11. Effect of estrogen on calcium absorption and serum vitamin D metabolites in postmenopausal osteoporosis.
Gallagher JC; Riggs BL; DeLuca HF
J Clin Endocrinol Metab; 1980 Dec; 51(6):1359-64. PubMed ID: 6255005
[TBL] [Abstract][Full Text] [Related]
12. Calculated free and bioavailable vitamin D metabolite concentrations in vitamin D-deficient hip fracture patients after supplementation with cholecalciferol and ergocalciferol.
Glendenning P; Chew GT; Inderjeeth CA; Taranto M; Fraser WD
Bone; 2013 Oct; 56(2):271-5. PubMed ID: 23792937
[TBL] [Abstract][Full Text] [Related]
13. Evidence that increased circulating 1 alpha, 25-dihydroxyvitamin D is the probable cause for abnormal calcium metabolism in sarcoidosis.
Bell NH; Stern PH; Pantzer E; Sinha TK; DeLuca HF
J Clin Invest; 1979 Jul; 64(1):218-25. PubMed ID: 312811
[TBL] [Abstract][Full Text] [Related]
14. Influence of vitamin D on parathyroid function in the elderly.
Quesada JM; Coopmans W; Ruiz B; Aljama P; Jans I; Bouillon R
J Clin Endocrinol Metab; 1992 Aug; 75(2):494-501. PubMed ID: 1639950
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D metabolites and calcium metabolism in patients with nephrotic syndrome and normal renal function.
Goldstein DA; Haldimann B; Sherman D; Norman AW; Massry SG
J Clin Endocrinol Metab; 1981 Jan; 52(1):116-21. PubMed ID: 6969729
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D metabolites in diabetic patients: decreased serum concentration of 24,25-dihydroxyvitamin D.
Christiansen C; Christensen MS; McNair P; Nielsen B; Madsbad S
Scand J Clin Lab Invest; 1982 Oct; 42(6):487-91. PubMed ID: 6760373
[TBL] [Abstract][Full Text] [Related]
17. Mineral metabolism in chronic renal failure with special reference to serum concentrations of 1.25(OH)2D and 24.25(OH)2D.
Christiansen C; Christensen MS; Melsen F; Rødbro P; DeLuca HF
Clin Nephrol; 1981 Jan; 15(1):18-22. PubMed ID: 7214748
[TBL] [Abstract][Full Text] [Related]
18. Plasma concentrations of 1,25-dihydroxyvitamin D, 24,25-dihydroxyvitamin D, and 25,26-dihydroxyvitamin D in the first year of life.
Markestad T
J Clin Endocrinol Metab; 1983 Oct; 57(4):755-9. PubMed ID: 6604063
[TBL] [Abstract][Full Text] [Related]
19. Effect of parathyroid hormone on 1,25-dihydroxyvitamin D formation in type I pseudohypoparathyroidism.
Aksnes L; Aarskog D
J Clin Endocrinol Metab; 1980 Dec; 51(6):1223-6. PubMed ID: 6255001
[TBL] [Abstract][Full Text] [Related]
20. Effect of 25-hydroxyvitamin D3 on vitamin D metabolites in primary biliary cirrhosis.
Kaplan MM; Goldberg MJ; Matloff DS; Neer RM; Goodman DB
Gastroenterology; 1981 Oct; 81(4):681-5. PubMed ID: 6973499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
